Renal Function after Renal Transplantation in Patients with Metabolic Syndrome

Document Type : Original Article (s)

Authors

1 Professor, Isfahan Kidney Diseases Research Center AND Department of Internal Medicine, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

2 Student of Medicine, Student Research Committee, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

3 Associate Professor, Isfahan Kidney Diseases Research Center AND Department of Internal Medicine, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

4 Professor, Department of Biostatistics and Epidemiology, School of Health, Isfahan University and Medical Sciences, Isfahan, Iran

5 Specialist in Community and Preventive Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

6 Isfahan Kidney Diseases Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

Abstract

Background: Recently, renal transplantation has increased worldwide. The incidence of metabolic syndrome is common after renal transplantation that might reduce renal function and increase cardiovascular complications. In this study, we compared renal function after renal transplantation in patients with or without metabolic syndrome.Methods: This cohort prospective study was conducted in 2017 among patients with renal transplantation aged more than 20 years in Isfahan City, Iran. Metabolic syndrome criteria including blood pressure, fasting blood sugar, high- and low-density lipoprotein, triglyceride, and waist circumference, as well as serum creatinine were measured in 30 patients with metabolic syndrome and 30 without metabolic syndrome in one-year follow-up period.Findings: 17 patients were women and 43 were men. The mean serum creatinine changes were not significantly different among the patients with or without metabolic syndrome (P = 0.227) in 1-year follow up. There was no significant association between serum creatinine level with metabolic syndrome criteria such as waist circumference (P = 0.214), diastolic blood pressure (P = 0.061), triglyceride (P = 0.409), high-density lipoprotein (P = 0.315), and fasting blood sugar (P = 0.284) in patients with metabolic syndrome, and only the association between serum creatinine level and systolic blood pressure was significant (P = 0.008).Conclusion: Serum creatinine did not increase significantly in patients with metabolic syndrome. We recommend to consider longer follow-up periods in future studies.

Keywords

References

  1. Collins AJ, Foley RN, Chavers B, Gilbertson D, Herzog C, Ishani A, et al. US Renal Data System 2013 Annual Data Report. Am J Kidney Dis 2014; 63(1 Suppl): A7.
  2. Scolari MP, Cappuccilli ML, Lanci N, La MG, Comai G, Persici E, et al. Predictive factors in chronic allograft nephropathy. Transplant Proc 2005; 37(6): 2482-4.
  3. Oda E. Metabolic syndrome: its history, mechanisms, and limitations. Acta Diabetol 2012; 49(2): 89-95.
  4. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001; 285(19): 2486-97.
  5. Grundy SM, Brewer HB, Jr., Cleeman JI, Smith SC, Jr., Lenfant C. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004; 109(3): 433-8.
  6. Bayer ND, Cochetti PT, Anil Kumar MS, Teal V, Huan Y, Doria C, et al. Association of metabolic syndrome with development of new-onset diabetes after transplantation. Transplantation 2010; 90(8): 861-6.
  7. Faenza A, Fuga G, Nardo B, Donati G, Cianciolo G, Scolari MP, et al. Metabolic syndrome after kidney transplantation. Transplant Proc 2007; 39(6): 1843-6.
  8. Bellinghieri G, Bernardi A, Piva M, Pati T, Stoppa F, Scaramuzzo P, et al. Metabolic syndrome after kidney transplantation. J Ren Nutr 2009; 19(1): 105-10.
  9. Porrini E, Delgado P, Bigo C, Alvarez A, Cobo M, Checa MD, et al. Impact of metabolic syndrome on graft function and survival after cadaveric renal transplantation. Am J Kidney Dis 2006; 48(1): 134-42.
  10. Stevens LA, Coresh J, Greene T, Levey AS. Assessing kidney function--measured and estimated glomerular filtration rate. N Engl J Med 2006; 354(23): 2473-83.
  11. Mohsin N, Mourad G, Faure M, Szawarc I, Bringer J. Metabolic syndrome performs better than the individual factors in predicting renal graft outcome. Transplant Proc 2013; 45(10): 3517-9.
  12. Shu KH, Wu MJ, Chen CH, Cheng CH, Yu TM, Chuang YW, et al. Short-term prospective study of metabolic syndrome in renal transplant recipients. Transplant Proc 2014; 46(2): 540-2.
  13. Javidi-Dasht-Bayaz R, Nazemian F, Jafari M, Tousi M. Prevalence of Metabolic Syndrome after Renal Transplantation and its Effect on Renal Function. Med J Mashad Univ Med Sci 2017; 60(3): 510-6. [In Persian].
  14. de Vries AP, Bakker SJ, van Son WJ, van der Heide JJ, Ploeg RJ, The HT, et al. Metabolic syndrome is associated with impaired long-term renal allograft function; not all component criteria contribute equally. Am J Transplant 2004; 4(10): 1675-83.
Journal of Isfahan Medical School
Volume 36, Issue 495 - Serial Number 495
July and August 2018
Pages 1057-1063

Files

History

  • Receive Date: 10 September 2018
  • Revise Date: 27 May 2024
  • Accept Date: 06 April 2022

Share

How to cite

Statistics